ArticleCancer science2023

Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B-cell lymphomas.

Yoko Katsuragawa-Taminishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.